Search

Your search keyword '"Markku V"' showing total 198 results

Search Constraints

Start Over You searched for: Author "Markku V" Remove constraint Author: "Markku V"
198 results on '"Markku V"'

Search Results

1. Tensin-2 interactomics reveals interaction with GAPDH and a phosphorylation-mediated regulatory role in glycolysis

2. Results of two cross-sectional database analyses regarding nap-induced modulations of tinnitus

5. Making a Contribution to Entrepreneurship Research by Studying Crowd-Funded Entrepreneurial Opportunities

6. Contextual status effects: The performance effects of host-country network status and regulatory institutions in cross-border venture capital

7. TWINGEN: protocol for an observational clinical biobank recall and biomarker cohort study to identify Finnish individuals with high risk of Alzheimer’s disease

8. Enhancing rigor in quantitative entrepreneurship research

9. The role of cognitive load in effective strategic issue management

10. Dampened Regulatory Circuitry of TEAD1/ITGA1/ITGA2 Promotes TGFβ1 Signaling to Orchestrate Prostate Cancer Progression

11. Whole-exome sequencing reveals candidate high-risk susceptibility genes for endometriosis

13. Venturing into the unknown with strangers: Substitutes of relational embeddedness in cross-border partner selection in venture capital syndicates

14. Attention Across Borders: Investor Attention as a Driver of Investment Choices in Cross-Border Equity Crowdfunding

15. Keratin 7 expression in different anatomical parts of colonic epithelium in inflammatory bowel diseases and its prognostic value: a 3-year follow-up study

16. ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity

17. Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells

18. Local Partnering in Foreign Ventures: Uncertainty, Experiential Learning, and Syndication in Cross-Border Venture Capital Investments

19. Driven by aspirations, but in what direction? Performance shortfalls, slack resources, and resource-consuming vs. resource-freeing organizational change

20. Migration and the choice between acquisitions and alliances An information economics perspective

22. Top Management’s Attention to Discontinuous Technological Change: Corporate Venture Capital as an Alert Mechanism

23. Emergence of Industries: A Review and Future Directions

25. Supply-side network effects and the development of information technology standards

26. CEO entrepreneurial orientation, entrenchment, and firm value creation

27. Do networks of financial intermediaries help reduce local bias? Evidence from cross-border venture capital exits

28. Geochemical and Characteristics of Mafic and Ultramafic Rocks of the Suprasubduction Zone Mawat Ophiolite, NE Iraq

29. Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance

31. Zircon dating of the basalt and felsic dyke in Haveri, SW Finland

32. An extracellular receptor tyrosine kinase motif orchestrating intracellular STAT activation

33. Drivers of holding period firm-level returns in private equity-backed buyouts

35. The temporal effects of relative and firm-level absorptive capacity on interorganizational learning

36. Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention

37. Cross‐Border Venture Capital and Private Equity

38. Transferability of the venture capital model to the corporate context: Implications for the performance of corporate venture units

39. TRANSFERABILITY OF THE VENTURE CAPITAL MODEL TO THE CORPORATE VENTURE UNIT CONTEXT

40. Attracting cross-border venture capital: the role of a local investor

41. Comprehensive characterization of the embryonic factor LEUTX

42. Acquiring financial resources from foreign equity capital markets: An examination of factors influencing foreign initial public offerings

43. Profit distribution and compensation structures in publicly and privately funded hybrid venture capital funds

44. THE TIMING OF KNOWLEDGE FLOWS IN INTERORGANIZATIONAL RELATIONSHIPS

45. Allocation of Attention to Portfolio Companies and the Performance of Venture Capital Firms

46. Interorganizational Commitment in Syndicated Cross–Border Venture Capital Investments

47. Analysis of human brain tissue derived from DBS surgery

48. New ventures' inward licensing: examining the effects of industry and strategy characteristics

49. What Drives Micro-Angel Investments?

50. Cross-border venture capital and new venture internationalization: An isomorphism perspective

Catalog

Books, media, physical & digital resources